Moderna says on track to report late-stage COVID-19 vaccine data next month

From Manas Mishra
(Reuters) - Moderna Inc <MRNA.O> is well on its way to reporting early data from a late-night trial of its COVID-19 vaccine candidate next month, the company said Thursday, offering the clearest timeline yet for when World know if the vaccine is effective.
The company, a frontrunner in the global race to make a vaccine, said its independent data monitoring committee is expected to conduct an interim review of its ongoing study of 30,000 late-stage volunteers in November.
Moderna expects two-month safety data, as required by the US Food and Drug Administration, in the second half of November. Then an emergency permit is requested.
The Cambridge, Massachusetts-based company has signed contracts with the US government and several other countries and is in discussions with a WHO-led group to deliver the vaccine.
Moderna, which has no approved products yet, is one of a handful of companies in final trials for the vaccine, along with major drug companies such as Johnson & Johnson <JNJ.N> and Pfizer Inc <PFE.N>.
"I believe when we bring our COVID-19 vaccine to market, 2021 could be the most important flexion year in Moderna's history," said Stéphane Bancel, Chief Executive Officer.
The company said it was in talks with the World Health Organization-backed COVAX facility about a tiered price proposal for its vaccine.

(Reporting by Manas Mishra and Manojna Maddipatla in Bengaluru; editing by Saumyadeb Chakrabarty)

Click to receive the most important news as a notification!

Last News

A single act of generosity led to COVID fatally spreading through this New Jersey household

Build Explosive Biceps with this Double-Action Curl

The Sun Is Experiencing a Second Fusion

Education Secretary Betsy Devos calls student debt forgiveness 'a truly insidious notion' and free college 'a socialist takeover'

Get a First Look at Martha's Latest Clothing Collection Available at Walmart

Supreme Court may give President Trump time to test census policy against undocumented immigrants